Full Year and Q4 Fiscal 2025 Earnings Results N O V E M B E R 1 7 , 2 0 2 5 Fiscal 2025 Earnings Results Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect our current expectations as to future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. These statements include, but are not limited to, statemen ...

Company Overview - NIU was founded in 2014 [3] - The company has 4,542 stores in China [3, 29] and operates in 53 countries [3, 29] - NIU has sold 6.1 million scooters globally [3] Sales Performance (3Q2025) - China sales volume reached 451,000 units, a 74% year-over-year increase [41] - Overseas sales volume was 36,000 units, a 65% year-over-year increase [41] - Total revenue reached RMB 1,694 million, an 11% year-over-year increase [41] Financial Position (as of September 30, 2025) - Cash, restricted cash, deposits & short-term investment totaled RMB 1,796 million [47] - Total assets amounted to RMB 3,394 million [47] - Total liabilities reached RMB 2,406 million [47] Financial Metrics - Gross margin was 21.8% of revenues [45] - Adjusted operating expenses were 13.8% of revenues [45] - Net margin was -4.0% [50] - Adjusted net margin was 5.2% [53] Production Capacity - The company has a total production capacity of approximately 2 million units per year [33, 36]

Third Quarter 2025 Investor Presentation Yatsen Holding Limited Disclaimer This presentation has been prepared by Yatsen Holding Limited (the "Company") solely for information purpose. By viewing or accessing the information contained in this material, you hereby acknowledge and agree that no representations, warranties or undertakings, express or implied, are made by the Company or any of its directors, shareholders, employees, agents, affiliates, advisors or representatives as to, and no reliance should b ...

Disclaimer ⯝餓㡮僈 H World Group Limited (NASDAQ: HTHT and HKEX: 1179) H World November 17, 2025 Third Quarter of 2025 Earnings Call This presentation has been prepared by H World Group Limited (the "H World") solely for informational purposes and should not be construed to be, directly or indirectly, in whole or in part, an offer to buy or sell and/or an invitation and/or a recommendation and/or a solicitation of an offer to buy or sell any security or instrument or to participate in any investment or trading ...

Q3 2025 Earnings November 2025 Disclaimer This presentation has been prepared by Full Truck Alliance Co. Ltd. (the "Company") solely for informational purposes and has not been independently verified. No representations or warranties, express or implied, are made by the Company or any of its affiliates, directors, officers, employees, advisors, or representatives with respect to, and no reliance should be placed on, the accuracy, fairness or completeness of the information presented or contained in these ma ...

2025 Informa Capital Markets Day Compounding Growth 17 November 2025 Welcome to Dubai! Welcome to Dubai! Welcome to Dubai! Welcome to Dubai! Day 1: Compounding Growth Day 2: Dubai Airshow • Management presentations • Leadership conversations • Product demonstrations • Networking • Hosted tour • Keynote speeches • Customer engagement • The Air Display Compounding Growth Schedule for today* | Dubai (UK GMT) | | | | --- | --- | --- | | 14:30 | Compounding Growth | His Excellency Helal Saeed Al Marri and Stephe ...

Overview: This presentation (this "Presentation") dated November 17, 2025, has been prepared by Southern Cross Gold Consolidated Ltd ("SXGC" or the "Company") and is authorized for release by Managing Director, Michael Hudson. Sunday Creek An Expanding and Significant Global Gold Discovery Michael Hudson Managing Director AGM - 17 November 2025 For personal use only Accuracy of Information: Readers are directed to the public disclosure of Southern Cross Gold Consolidated Ltd ("SXGC") available under SXGC's ...

Financial Data and Key Metrics Changes - Total revenue for the first nine months of 2025 was approximately $2.8 million, a decrease of about $1 million or 27% compared to $3.8 million in the same period in 2024, reflecting a strategic shift away from legacy contract work [18] - Cost of revenue rose to approximately $2.8 million, a 48% increase from $1.9 million during the first nine months of 2024 [18] - Gross loss for the period was approximately $4 million, compared to a loss of about $719,000 in the same period last year [19] - Selling general and administrative expenses totaled $13 million, compared to $9.9 million in the prior year, reflecting key growth initiatives [20] - Net loss for Q3 2025 was $6 million compared to $3.9 million in the same period of the prior year [24] Business Line Data and Key Metrics Changes - The company is transitioning from legacy high-margin contracts to higher-value commercial space-based and AI-driven solutions, which is expected to generate more sustainable recurring revenue in future periods [18] - The gross loss increase was primarily due to higher depreciation from recently capitalized assets and reduced contributions from legacy services [23] Market Data and Key Metrics Changes - The company is seeing strong momentum internationally, especially among allies seeking sovereign U.S. origin multi-domain capabilities [31] - Greater budget clarity within the U.S. is helping stabilize and improve program timelines, which is viewed as an upside [31] Company Strategy and Development Direction - The company is evolving into a diversified space and defense innovator, focusing on full-spectrum solutions from design and manufacturing to on-orbit operations and data services [5] - The vertically integrated model enables scalability and efficiency, allowing rapid entry into new markets and development of recurring revenue streams [10] - The company is strategically investing in infrastructure, technology, and team to build capabilities comparable to larger competitors with less capital [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience and adaptability regardless of external landscape challenges, including government funding uncertainties [7] - The company is positioned to meet rising global demand for resilient, secure, and cost-effective space capabilities [11] - The recent capital raises are intended to fund product commercialization, LISIS-AT scaling, and AI development [32] Other Important Information - The company completed two successful capital raises, receiving approximately $15.5 million of net proceeds [24] - The LISIS-AT platform is increasingly software-defined, enabling rapid in-orbit reconfiguration and performance optimization [11] Q&A Session Summary Question: What is the commercialization timeline for Fortis VPX? - The first three VPX products remain on track for release to production in January of 2026, with customer integrations and revenue contributions expected shortly thereafter [29] Question: Can you update on the commissioning timeline for LISIS-AT 3? - The commissioning is progressing well, with multiple payloads and sensors, and additional satellites in production will expand hosted payload capability and data availability [30] Question: Are customers already evaluating Fortis VPX or FeatherEdge? - Active early access programs are in place with both government and commercial customers, with several transitioning toward multi-year hardware agreements [31] Question: What does your geographic revenue mix look like going forward? - Strong momentum is seen internationally, especially among allies, with greater budget clarity in the U.S. improving program timelines [31] Question: How does the recent capital raise position the company? - The capital raise funds a significant portion of near-term product commercialization, LISIS-AT scaling, and AI development [32] Question: Can you expand on alignment with the DOD's Golden Dome vision? - The company's technology roadmap aligns directly with the DOD's Golden Dome vision, focusing on resilient, distributed, multi-layered sensing and communications architecture [32] Question: What is the potential market for your lunar-capable LISIS-AT Lunar platform? - The company believes its early mover position creates a strategic opportunity in the expanding lunar exploration and infrastructure programs [33]

Financial Data and Key Metrics Changes - The company reported revenues of $303,000 for the quarter, representing a 51% increase compared to the same quarter last year [8] - For the first half of the fiscal year, revenues increased by 85% to over $600,000, marking the best first half ever for the company [5][8] - Gross profit totaled $220,000, or 72.6% of revenues, which was a 23% increase from $180,000, or 89.5% of revenues in the same quarter a year ago [9] - Net loss totaled $3 million, or $0.11 per share, compared to a net loss of $2.2 million in the same quarter last year [10] - Available cash increased to $768,000 from $220,000 at the end of the previous fiscal year [11] Business Line Data and Key Metrics Changes - The U.S. distributor network increased sales by 35% year-over-year, contributing $237,000, or 75% of total revenues for the quarter [4][8] - The new product, Precise PRP, generated increased revenue during the quarter, with 42% of revenue attributed to PRP and 58% to Spring [34] Market Data and Key Metrics Changes - The veterinary healthcare market in Mexico is projected to grow at a CAGR of 11%, reaching approximately $2.4 billion in six years [3] - The European animal market is estimated at over $16.56 billion and is projected to grow at a CAGR of 8.6% [3] - The U.K. market exceeds $2.6 billion and is growing at a 7.8% CAGR [4] Company Strategy and Development Direction - The company aims to expand the use of its flagship product, Spring, and increase awareness of Precise PRP for treating osteoarthritis in animals [13] - The company is exploring the introduction of products to human markets and has formed partnerships to enhance its market presence [7][18] - A strategic collaboration with Digital Landia aims to integrate AI technology into the company's platform, enhancing diagnostic capabilities [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued strong sales momentum and market penetration for the remainder of fiscal 2026 [27] - The company anticipates another year of record growth and improving bottom line as it expands the use of Spring and Precise PRP [27] - The third and fourth quarters are expected to be particularly strong due to increased industry events driving product awareness [28] Other Important Information - The company qualified to begin trading on the OTCQX best market, enhancing visibility and liquidity for investors [12] - The appointment of Josh Rubin to the board of directors is expected to provide valuable insights into growth-stage companies [6] Q&A Session Summary Question: How many clinics are heavy users of the product? - The learning curve for veterinarians to adopt the product ranges from six months to a year, with anecdotal evidence showing continued growth in adoption [32] Question: Can you break down the revenue between Spring and PRP? - Approximately 42% of revenue was from PRP and 58% from Spring, with the PRP revenue only reflecting the canine version as equine shipments just began [34][35] Question: Do you have any corporate clinics that have adopted your product corporate-wide? - No corporate-wide adoption has occurred yet, as each corporate clinic allows veterinarians to make their own decisions [37] Question: Can you provide a breakdown between companion versus equine revenue? - The company tracks these markets separately and plans to provide more detailed segment reporting in the future [39]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 totaled approximately $384,000, a significant increase from $101,000 in the same period last year, primarily due to growth in research and development services contracts and custom hardware contracts [13] - Gross margin improved to 33% compared to 9% in Q3 2024, although variability is expected due to a small number of active contracts [14] - Net income for Q3 2025 was $2.4 million, or approximately $0.01 per share, compared to a net loss of $5.7 million in Q3 2024 [16] - Total assets increased to $898 million as of September 30, 2025, up from $154 million at year-end 2024 [17] Business Line Data and Key Metrics Changes - The company recorded revenue from the NASA LIDAR initiative and completed a transaction with a major U.S. financial institution, validating its quantum AI and security platforms [7] - Revenue recognition began for cloud-based access to the Direct3 quantum optimization system during Q3 [14] Market Data and Key Metrics Changes - The company is seeing growing adoption of quantum and photonic solutions across research, enterprise, and government sectors, indicating a positive trend in market demand [7] - The integrated photonics platform is positioned to address global energy constraints and computational demands, making it relevant for various sectors [11] Company Strategy and Development Direction - The company aims to transition from prototype and small-batch manufacturing to volume production by the end of the decade, focusing on refining processes and expanding facilities [5][12] - The long-term strategy includes evaluating acquisition opportunities to accelerate the vision of making quantum technology accessible [15] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of scaling engineering and manufacturing capabilities and strengthening relationships across government, industry, and academia [19] - The company is positioned to deliver energy-efficient room-temperature quantum devices, which are critical for the next generation of computing [11] Other Important Information - The company raised $500 million in Q3 and an additional $750 million post-quarter, significantly strengthening its balance sheet [3][15] - Operating expenses increased to $10.5 million in Q3 2025, reflecting growth in personnel across various departments [16] Q&A Session Summary Question: Details on Poet Technologies partnership - Management discussed active talks with multiple parties on using thin-film lithium niobate technology for high-speed transceiver technology, highlighting the collaboration with Poet Technologies [22] Question: Use cases for quantum security solutions - Management mentioned discussions with firms to apply quantum communication technology to aerospace platforms and the potential for smaller quantum communication systems [23][24] Question: M&A opportunities and market conditions - Management acknowledged the volatile M&A market and is actively evaluating acquisition candidates to enhance customer revenue and technology roadmap [26][27] Question: CapEx for Fab 1 and plans for Fab 2 - Fab 1 is fully operational with an additional CapEx of about $2 million planned for high-speed testing equipment, while Fab 2 is being scoped for both internal needs and external demand [35][36] Question: International opportunities - Management confirmed active discussions for international partnerships and sales, including projects in Europe and South Korea [57]